Farringdon Capital’s Covista Inc CVSA Stock Holding History

Farringdon Capital’s Portfolio CVSA Stock Details CVSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,021	Closed	-$209K	–	377
2025 Q4	$209K	Buy	+2,021	New	+$231K	0.05%	388

Other funds holding CVSA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Farringdon Capital's CVSA Position: Q1 2026 in Review

Farringdon Capital sold out of Covista Inc (CVSA) in Q1 2026, closing a stake of 2,021 shares — an estimated $209K sold.

Farringdon Capital first reported a position in CVSA in Q4 2025 and held it in 1 quarter. The position peaked at $209K in Q4 2025. 353 funds tracked by Wall St. Rank hold CVSA as of Q1 2026.

Farringdon Capital reported no remaining Covista Inc position as of Q1 2026 after selling out during the quarter.
Farringdon Capital sold 2,021 Covista Inc shares in Q1 2026, an estimated $209K.
Farringdon Capital first reported a position in Covista Inc in Q4 2025 and held it in 1 quarter.
Farringdon Capital's Covista Inc position peaked at $209K in Q4 2025.
353 funds tracked by Wall St. Rank held Covista Inc as of Q1 2026.

Based on Farringdon Capital's 13F filing for Q1 2026, filed 15 May 2026.